Edgar A. Otto

Edgar A. Otto

Auto-generated profile, based on publicly available information

Edgar A. Otto

University of Michigan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
FGFrancesc R García Gonzalo
Francesc R García Gonzalo
KCKevin C Corbit
Kevin C Corbit
MSMaría Salomé Sirerol-Piquer
María Salomé Sirerol-Piquer
GRGokul Ramaswami
Gokul Ramaswami
EOEdgar A Otto
Edgar A Otto
JRJeremy F Reiter
Jeremy F Reiter
Jeremy Reiter and colleagues show that Tctn1 is a component of a transition zone complex that regulates ciliogenesis and ciliary membrane composition. They also identify a likely causal mutation in TCTN1 in two siblings with Joubert syndrome. Mutations affecting ciliary components cause ciliopathies. As described here, we investigated Tectonic1 (Tctn1), a regulator of mouse Hedgehog signaling, and found that it is essential for ciliogenesis in some, but not all, tissues. Cell types that do not require Tctn1 for ciliogenesis require it to localize select membrane-associated proteins to the cilium, including Arl13b, AC3, Smoothened and Pkd2. Tctn1 forms a complex with multiple ciliopathy proteins associated with Meckel and Joubert syndromes, including Mks1, Tmem216, Tmem67, Cep290, B9d1, Tctn2 and Cc2d2a. Components of this complex co-localize at the transition zone, a region between the basal body and ciliary axoneme. Like Tctn1, loss of Tctn2, Tmem67 or Cc2d2a causes tissue-specific defects in ciliogenesis and ciliary membrane composition. Consistent with a shared function for complex components, we identified a mutation in TCTN1 that causes Joubert syndrome. Thus, a transition zone complex of Meckel and Joubert syndrome proteins regulates ciliary assembly and trafficking, suggesting that transition zone dysfunction is the cause of these ciliopathies.

1 May 2011 in Cell
Verified
Journal Article
Closed access
LSLiyun Sang
Liyun Sang
JMJulie J. Miller
Julie J. Miller
KCKevin C. Corbit
Kevin C. Corbit
RGRachel H. Giles
Rachel H. Giles
MBMatthew J. Brauer
Matthew J. Brauer
PJPeter K. Jackson
Peter K. Jackson

20 July 2003 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EOEdgar A Otto
Edgar A Otto
Bernhard SchermerBernhard Schermer
Bernhard Schermer
TOTomoko Obara
Tomoko Obara
JOJohn F O'Toole
John F O'Toole
KHKarl S Hiller
Karl S Hiller
FHFriedhelm Hildebrandt
Friedhelm Hildebrandt

29 November 2001 in Nature
Verified
Journal Article
Closed access
PDF file
Raúl EstévezRaúl Estévez
Raúl Estévez
TBThomas Boettger
Thomas Boettger
VSValentin Stein
Valentin Stein
RBRalf Birkenhäger
Ralf Birkenhäger
EOEdgar Otto
Edgar Otto
TJThomas J. Jentsch
Thomas J. Jentsch

5 November 2006 in Nature Genetics
Verified
Journal Article
Open access
PDF file
BHBernward Hinkes
Bernward Hinkes
RWRoger C. Wiggins
Roger C. Wiggins
RGRasheed Gbadegesin
Rasheed Gbadegesin
CVChristopher N Vlangos
Christopher N Vlangos
Dominik SeelowDominik Seelow
Dominik Seelow
FHFriedhelm Hildebrandt
Friedhelm Hildebrandt
Nephrotic syndrome, a malfunction of the kidney glomerular filter, leads to proteinuria, edema and, in steroid-resistant nephrotic syndrome, end-stage kidney disease. Using positional cloning, we identified mutations in the phospholipase C epsilon gene (PLCE1) as causing early-onset nephrotic syndrome with end-stage kidney disease. Kidney histology of affected individuals showed diffuse mesangial sclerosis (DMS). Using immunofluorescence, we found PLCε1 expression in developing and mature glomerular podocytes and showed that DMS represents an arrest of normal glomerular development. We identified IQ motif–containing GTPase-activating protein 1 as a new interaction partner of PLCε1. Two siblings with a missense mutation in an exon encoding the PLCε1 catalytic domain showed histology characteristic of focal segmental glomerulosclerosis. Notably, two other affected individuals responded to therapy, making this the first report of a molecular cause of nephrotic syndrome that may resolve after therapy. These findings, together with the zebrafish model of human nephrotic syndrome generated by plce1 knockdown, open new inroads into pathophysiology and treatment mechanisms of nephrotic syndrome.

7 May 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
John SayerJohn Sayer
John Sayer
EOEdgar A Otto
Edgar A Otto
JOJohn F O'TOole
John F O'TOole
GNGudrun Nurnberg
Gudrun Nurnberg
MKMichael A Kennedy
Michael A Kennedy
FHFriedhelm Hildebrandt
Friedhelm Hildebrandt